Syndax Pharmaceuticals presented data at EHA Congress and is seeking successful regulatory approval for its drug pipeline.
2 reports, 1 independent
Updated Oct 1
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Syndax Pharmaceuticals presented data at EHA Congress and is seeking successful regulatory approval for its drug pipeline.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Syndax's drug was approved by the FDA and selected by TIME.1 source
Syndax Pharmaceuticals presented data and is seeking FDA approval for its drug pipeline.1 source
Keep exploring
The entities involved
-
Syndax Pharmaceuticals
business
Nothing else this week.
- FDA